RankingsPricing
  1. US-listed companies
  2. REGENERON PHARMACEUTICALS, INC.
  3. Financials
  4. Provision for income taxes

REGENERON PHARMACEUTICALS, INC.REGN

Market cap
$81.6B
P/E ratio
SummaryFinancials
Period EndProvision for income taxes (Million USD)YoY (%)
Dec 31, 2024367+49.49%
Dec 31, 2023246-52.79%
Dec 31, 2022520-58.38%
Dec 31, 20211,251+320.76%
Dec 31, 2020297-5.14%
Dec 31, 2019313+187.17%
Dec 31, 2018109-87.60%
Dec 31, 2017880+102.63%
Dec 31, 2016434-26.27%
Dec 31, 2015589+37.73%
Dec 31, 2014428+47.98%
Dec 31, 2013289-186.05%
Dec 31, 2012-336+29568.55%
Dec 31, 2011-1-Infinity%
Dec 31, 20100

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)